Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Interest Expenses (2020 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) reported Interest Expenses of $82.05 million for Q2 2026, up 33.5% from $61.46 million a year earlier and up 18.4% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Interest Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alnylam Pharmaceuticals' Interest Expenses came in at $261.14 million, up 35.2% year-over-year; for FY2025, it was $252.63 million, up 78.1% from FY2024.

  • Interest Expenses has a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
  • By year, Interest Expenses came in at $141.86 million in FY2024 (+17.0%), $121.22 million in FY2023 (-22.3%), $155.97 million in FY2022 (+9.1%) and $143.02 million in FY2021 (+69.3%).
  • The Q2 2026 figure ranks as the highest quarterly Interest Expenses in data going back to Q2 2020.
  • Year over year, Interest Expenses has now increased in each of the last 11 quarters, with growth averaging 41.9% over the last eight quarters.
  • The high point for year-over-year Interest Expenses in five years was Q2 2025 (growth of 84.8%); the low point was Q1 2023 (a decline of 31.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $69.29 million (Q1 2026), $65.4 million (Q4 2025) and $44.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 281.00 Mn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -435.00 Mn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 82.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82.05 Mn
Mar 31, 2026 69.29 Mn
Dec 31, 2025 65.40 Mn
Sep 30, 2025 44.40 Mn
Jun 30, 2025 61.46 Mn
Mar 31, 2025 58.31 Mn
Dec 31, 2024 38.97 Mn
Sep 30, 2024 34.38 Mn
Jun 30, 2024 33.26 Mn
Mar 31, 2024 35.25 Mn
Dec 31, 2023 31.34 Mn
Sep 30, 2023 30.89 Mn
Jun 30, 2023 30.04 Mn
Mar 31, 2023 28.96 Mn
Dec 31, 2022 29.91 Mn
Sep 30, 2022 41.08 Mn
Jun 30, 2022 42.61 Mn
Mar 31, 2022 42.36 Mn
Dec 31, 2021 36.82 Mn
Sep 30, 2021 40.27 Mn
API Access

Alnylam Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ALNY&period=max&api_key=YOUR_API_KEY